Showing results (51-60 of 130) with videos related to
Sort By:
Pageof 13
Therapeutic Advances in Gastroenterology|June 9, 2021
Experience with regorafenib in the treatment of hepatocellular carcinomaAlessandro Granito, Antonella Forgione, Sara Marinelli, et al.Cancers|January 21, 2022
Prognosis of Single Early-Stage Hepatocellular Carcinoma (HCC) with CEUS Inconclusive Imaging (LI-RADS LR-3 and LR-4) Is No Better than Typical HCC (LR-5)Eleonora Terzi, Alice Giamperoli, Massimo Iavarone, et al.Immunotherapy|August 21, 2025
Pure red cell aplasia due to Parvovirus B19 infection and atezolizumab: case report and literature reviewDante Pio Pallotta, Bernardo Stefanini, Agnese Pratelli, et al.Archives of Iranian Medicine|November 12, 2013
Fulminant type 1 autoimmune hepatitis in a recently diagnosed celiac disease patientUmberto Volta, Kamran Rostami, Francesco Tovoli, et al.Journal of Clinical Medicine|January 23, 2024
Autoimmune Polyendocrine Syndromes in Adult Italian Celiac Disease PatientsDante Pio Pallotta, Alessandro Granito, Alberto Raiteri, et al.Life (Basel, Switzerland)|November 25, 2023
Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain?Ingrid Garajová, Fabio Gelsomino, Massimiliano Salati, et al.Cancers|April 1, 2020
Treatment of Combined Hepatocellular and CholangiocarcinomaSimona Leoni, Vito Sansone, Stefania De Lorenzo, et al.Journal of Clinical Medicine|August 12, 2022
The Feasibility of Liver Biopsy for Undefined Nodules in Patients under Surveillance for Hepatocellular Carcinoma: Is Biopsy Really a Useful Tool?Matteo Renzulli, Anna Pecorelli, Nicolò Brandi, et al.Cancers|March 29, 2023
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab-Bevacizumab in Hepatocellular CarcinomaCatia Giovannini, Fabrizia Suzzi, Francesco Tovoli, et al.Journal of Clinical Immunology|April 6, 2013
Antibodies to deamidated gliadin peptides: an accurate predictor of coeliac disease in infancySergio Amarri, Patrizia Alvisi, Roberto De Giorgio, et al.Pageof 13